30 USD
+0.7 (+2.39%)
30 USD
0 (0%)
PNTG gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 102 industry peers in the Health Care Providers & Services industry. PNTG has only an average score on both its financial health and profitability. PNTG is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings could make PNTG a good candidate for growth investing.
1. Profitability
1.1 Basic Checks
- PNTG had positive earnings in the past year.
- PNTG had a positive operating cash flow in the past year.
- Each year in the past 5 years PNTG has been profitable.
- PNTG had a positive operating cash flow in 4 of the past 5 years.
1.2 Ratios
- Looking at the Return On Assets, with a value of 3.54%, PNTG is in the better half of the industry, outperforming 67.65% of the companies in the same industry.
- PNTG has a better Return On Equity (8.29%) than 68.63% of its industry peers.
- With a Return On Invested Capital value of 4.72%, PNTG perfoms like the industry average, outperforming 55.88% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for PNTG is significantly below the industry average of 9.21%.
- The last Return On Invested Capital (4.72%) for PNTG is above the 3 year average (3.91%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.29% | ||
| ROIC | 4.72% |
ROA(3y)2.36%
ROA(5y)2.14%
ROE(3y)7.56%
ROE(5y)8.28%
ROIC(3y)3.91%
ROIC(5y)3.28%
1.3 Margins
- PNTG has a Profit Margin of 3.15%. This is in the better half of the industry: PNTG outperforms 68.63% of its industry peers.
- In the last couple of years the Profit Margin of PNTG has grown nicely.
- With a decent Operating Margin value of 4.83%, PNTG is doing good in the industry, outperforming 62.75% of the companies in the same industry.
- PNTG's Operating Margin has improved in the last couple of years.
- Looking at the Gross Margin, with a value of 20.13%, PNTG is in line with its industry, outperforming 45.10% of the companies in the same industry.
- PNTG's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.83% | ||
| PM (TTM) | 3.15% | ||
| GM | 20.13% |
OM growth 3Y49.09%
OM growth 5Y24.56%
PM growth 3Y74.18%
PM growth 5Y34.45%
GM growth 3Y1.25%
GM growth 5Y-2.76%
2. Health
2.1 Basic Checks
- PNTG has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- PNTG has more shares outstanding than it did 1 year ago.
- PNTG has more shares outstanding than it did 5 years ago.
- PNTG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- PNTG has an Altman-Z score of 2.86. This is not the best score and indicates that PNTG is in the grey zone with still only limited risk for bankruptcy at the moment.
- PNTG has a Altman-Z score of 2.86. This is in the better half of the industry: PNTG outperforms 61.76% of its industry peers.
- The Debt to FCF ratio of PNTG is 0.93, which is an excellent value as it means it would take PNTG, only 0.93 years of fcf income to pay off all of its debts.
- PNTG has a Debt to FCF ratio of 0.93. This is amongst the best in the industry. PNTG outperforms 89.22% of its industry peers.
- A Debt/Equity ratio of 0.08 indicates that PNTG is not too dependend on debt financing.
- With a decent Debt to Equity ratio value of 0.08, PNTG is doing good in the industry, outperforming 77.45% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.93 | ||
| Altman-Z | 2.86 |
ROIC/WACC0.51
WACC9.28%
2.3 Liquidity
- A Current Ratio of 1.04 indicates that PNTG should not have too much problems paying its short term obligations.
- PNTG has a Current ratio of 1.04. This is in the lower half of the industry: PNTG underperforms 68.63% of its industry peers.
- PNTG has a Quick Ratio of 1.04. This is a normal value and indicates that PNTG is financially healthy and should not expect problems in meeting its short term obligations.
- PNTG has a worse Quick ratio (1.04) than 61.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.04 | ||
| Quick Ratio | 1.04 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 17.39% over the past year.
- Measured over the past years, PNTG shows a very strong growth in Earnings Per Share. The EPS has been growing by 50.93% on average per year.
- PNTG shows a strong growth in Revenue. In the last year, the Revenue has grown by 29.89%.
- Measured over the past years, PNTG shows a quite strong growth in Revenue. The Revenue has been growing by 15.48% on average per year.
EPS 1Y (TTM)17.39%
EPS 3Y26.9%
EPS 5Y50.93%
EPS Q2Q%15.38%
Revenue 1Y (TTM)29.89%
Revenue growth 3Y16.5%
Revenue growth 5Y15.48%
Sales Q2Q%26.76%
3.2 Future
- PNTG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.25% yearly.
- Based on estimates for the next years, PNTG will show a very strong growth in Revenue. The Revenue will grow by 21.76% on average per year.
EPS Next Y25.87%
EPS Next 2Y19.29%
EPS Next 3Y19.25%
EPS Next 5YN/A
Revenue Next Year34.92%
Revenue Next 2Y29.34%
Revenue Next 3Y21.76%
Revenue Next 5YN/A
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 27.78, which means the current valuation is very expensive for PNTG.
- 60.78% of the companies in the same industry are more expensive than PNTG, based on the Price/Earnings ratio.
- Compared to an average S&P500 Price/Earnings ratio of 27.32, PNTG is valued at the same level.
- The Price/Forward Earnings ratio is 22.43, which indicates a rather expensive current valuation of PNTG.
- PNTG's Price/Forward Earnings is on the same level as the industry average.
- Compared to an average S&P500 Price/Forward Earnings ratio of 24.30, PNTG is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.78 | ||
| Fwd PE | 22.43 |
4.2 Price Multiples
- PNTG's Enterprise Value to EBITDA is on the same level as the industry average.
- PNTG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 37.26 | ||
| EV/EBITDA | 21.18 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The decent profitability rating of PNTG may justify a higher PE ratio.
- PNTG's earnings are expected to grow with 19.25% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.07
PEG (5Y)0.55
EPS Next 2Y19.29%
EPS Next 3Y19.25%
5. Dividend
5.1 Amount
- No dividends for PNTG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
30
+0.7 (+2.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-25 2026-02-25/amc
Inst Owners95.38%
Inst Owner Change0.01%
Ins Owners4.71%
Ins Owner Change1.14%
Market Cap1.04B
Revenue(TTM)847.27M
Net Income(TTM)26.70M
Analysts87.69
Price Target35.36 (17.87%)
Short Float %2.66%
Short Ratio3.51
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.86%
Min EPS beat(2)-1.96%
Max EPS beat(2)5.67%
EPS beat(4)2
Avg EPS beat(4)3.3%
Min EPS beat(4)-1.96%
Max EPS beat(4)11.46%
EPS beat(8)5
Avg EPS beat(8)5.86%
EPS beat(12)7
Avg EPS beat(12)3.38%
EPS beat(16)8
Avg EPS beat(16)1.16%
Revenue beat(2)2
Avg Revenue beat(2)1.65%
Min Revenue beat(2)1.1%
Max Revenue beat(2)2.19%
Revenue beat(4)3
Avg Revenue beat(4)1.26%
Min Revenue beat(4)-0.34%
Max Revenue beat(4)2.19%
Revenue beat(8)7
Avg Revenue beat(8)2.77%
Revenue beat(12)11
Avg Revenue beat(12)3.01%
Revenue beat(16)14
Avg Revenue beat(16)2.5%
PT rev (1m)0%
PT rev (3m)3.17%
EPS NQ rev (1m)0.45%
EPS NQ rev (3m)6.19%
EPS NY rev (1m)0%
EPS NY rev (3m)2.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)22.15%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 27.78 | ||
| Fwd PE | 22.43 | ||
| P/S | 1.22 | ||
| P/FCF | 37.26 | ||
| P/OCF | 21.66 | ||
| P/B | 3.22 | ||
| P/tB | 26.66 | ||
| EV/EBITDA | 21.18 |
EPS(TTM)1.08
EY3.6%
EPS(NY)1.34
Fwd EY4.46%
FCF(TTM)0.81
FCFY2.68%
OCF(TTM)1.38
OCFY4.62%
SpS24.49
BVpS9.31
TBVpS1.13
PEG (NY)1.07
PEG (5Y)0.55
Graham Number15.04
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.54% | ||
| ROE | 8.29% | ||
| ROCE | 6.36% | ||
| ROIC | 4.72% | ||
| ROICexc | 4.74% | ||
| ROICexgc | 8.48% | ||
| OM | 4.83% | ||
| PM (TTM) | 3.15% | ||
| GM | 20.13% | ||
| FCFM | 3.29% |
ROA(3y)2.36%
ROA(5y)2.14%
ROE(3y)7.56%
ROE(5y)8.28%
ROIC(3y)3.91%
ROIC(5y)3.28%
ROICexc(3y)4%
ROICexc(5y)3.33%
ROICexgc(3y)6.26%
ROICexgc(5y)5.05%
ROCE(3y)5.26%
ROCE(5y)4.41%
ROICexgc growth 3Y73.2%
ROICexgc growth 5Y43.25%
ROICexc growth 3Y62.52%
ROICexc growth 5Y34.54%
OM growth 3Y49.09%
OM growth 5Y24.56%
PM growth 3Y74.18%
PM growth 5Y34.45%
GM growth 3Y1.25%
GM growth 5Y-2.76%
F-Score7
Asset Turnover1.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.93 | ||
| Debt/EBITDA | 0.53 | ||
| Cap/Depr | 250.49% | ||
| Cap/Sales | 2.37% | ||
| Interest Coverage | 17.4 | ||
| Cash Conversion | 97.82% | ||
| Profit Quality | 104.32% | ||
| Current Ratio | 1.04 | ||
| Quick Ratio | 1.04 | ||
| Altman-Z | 2.86 |
F-Score7
WACC9.28%
ROIC/WACC0.51
Cap/Depr(3y)260.04%
Cap/Depr(5y)213.36%
Cap/Sales(3y)2.47%
Cap/Sales(5y)2.14%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.39%
EPS 3Y26.9%
EPS 5Y50.93%
EPS Q2Q%15.38%
EPS Next Y25.87%
EPS Next 2Y19.29%
EPS Next 3Y19.25%
EPS Next 5YN/A
Revenue 1Y (TTM)29.89%
Revenue growth 3Y16.5%
Revenue growth 5Y15.48%
Sales Q2Q%26.76%
Revenue Next Year34.92%
Revenue Next 2Y29.34%
Revenue Next 3Y21.76%
Revenue Next 5YN/A
EBIT growth 1Y23.28%
EBIT growth 3Y73.69%
EBIT growth 5Y43.85%
EBIT Next Year48.58%
EBIT Next 3Y30.05%
EBIT Next 5YN/A
FCF growth 1Y92.21%
FCF growth 3YN/A
FCF growth 5Y46.34%
OCF growth 1Y99.77%
OCF growth 3YN/A
OCF growth 5Y32.7%
PENNANT GROUP INC/THE / PNTG FAQ
Can you provide the ChartMill fundamental rating for PENNANT GROUP INC/THE?
ChartMill assigns a fundamental rating of 5 / 10 to PNTG.
What is the valuation status of PENNANT GROUP INC/THE (PNTG) stock?
ChartMill assigns a valuation rating of 4 / 10 to PENNANT GROUP INC/THE (PNTG). This can be considered as Fairly Valued.
Can you provide the profitability details for PENNANT GROUP INC/THE?
PENNANT GROUP INC/THE (PNTG) has a profitability rating of 6 / 10.
How financially healthy is PENNANT GROUP INC/THE?
The financial health rating of PENNANT GROUP INC/THE (PNTG) is 5 / 10.
What is the expected EPS growth for PENNANT GROUP INC/THE (PNTG) stock?
The Earnings per Share (EPS) of PENNANT GROUP INC/THE (PNTG) is expected to grow by 25.87% in the next year.